Working… Menu
Trial record 1 of 1 for:    02574078
Previous Study | Return to List | Next Study

A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) (CheckMate370)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02574078
Recruitment Status : Completed
First Posted : October 12, 2015
Last Update Posted : March 15, 2021
Information provided by (Responsible Party):
Bristol-Myers Squibb

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : April 15, 2020
Actual Study Completion Date : April 15, 2020
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 15, 2021
April 7, 2021